📋 FDA Reference

Dorado PTA Balloon Dilatation Catheter

Bard Peripheral Vascular, Inc.

Contact Bard Peripheral Vascular, Inc. ↗ Compare similar devices

Summary: The Dorado PTA Balloon Dilatation Catheter is a medical device used to treat stenosis in blood vessels. It is primarily used by interventional radiologists and vascular surgeons.

FDA Clearance Information

Pathway ? 510(k)
Number ? K072283 ↗
Decision Date ? September 19, 2007
Product Code ? DQY Catheter, Percutaneous
Device Class ? Class 2
Evidence ? 0 studies

The Dorado PTA Balloon Dilatation Catheter was cleared through the FDA 510(k) pathway on September 19, 2007. It is manufactured by Bard Peripheral Vascular and classified as a Class 2 device.

What It Is

The Dorado PTA Balloon Dilatation Catheter is designed for percutaneous transluminal angioplasty (PTA) procedures. It works by inflating a balloon within a blood vessel to dilate stenotic segments, improving blood flow. This device is particularly useful in treating peripheral arterial disease and is engineered for flexibility and precision in challenging vascular anatomy.

FDA-Cleared Indications

  • Dilation of stenotic segments in peripheral blood vessels during percutaneous transluminal angioplasty.
  • Use in the peripheral vasculature to improve blood flow through narrowed vessel segments.

Clinical Applications

  • Balloon angioplasty of stenotic peripheral arteries.
  • Treatment of narrowed lower-extremity vessels in patients with peripheral vascular disease.
  • Dilation of peripheral venous stenoses when consistent with the device labeling and selected catheter configuration.
  • Angioplasty of stenoses in dialysis access circuits, when the specific device labeling permits this application.

Reported off-label uses

  • Treatment of selected stenoses in vascular territories or lesion types not specifically described in the device labeling.
  • Use in complex or heavily calcified lesions beyond the labeled indications, based on operator judgment and institutional practice.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The catheter is available in different balloon diameters and lengths; the selected size should match the target vessel and lesion.
  • It is advanced over a compatible guidewire through an appropriately sized vascular sheath or access system under fluoroscopic imaging.
  • The balloon must be inflated and deflated according to the device instructions for use. Excessive pressure or incorrect sizing can cause vessel injury.
  • MRI safety depends on the exact catheter configuration and whether the device remains in the patient; consult the current manufacturer labeling before MRI.
  • Contraindications and precautions include inability to cross the lesion, unsuitable vessel anatomy, severe uncorrected coagulation abnormalities, and allergy or intolerance to materials or contrast when relevant.

Related Literature

The linked study investigated the use of drug-eluting balloon angioplasty for recurrent cephalic arch stenosis in dialysis fistulas. While the abstract is not available, such studies typically focus on the efficacy of drug-eluting technology in reducing restenosis rates. Limitations may include sample size and lack of long-term follow-up data.

Frequently Asked Questions

What is the Dorado PTA Balloon Dilatation Catheter used for?

It is used to dilate stenotic segments of blood vessels, improving blood flow in patients with peripheral vascular disease.

What specialties typically use this device?

Interventional radiologists and vascular surgeons commonly use this device in their procedures.

What are the FDA-cleared indications?

The device is indicated for dilating stenotic segments of blood vessels, particularly in patients with peripheral vascular disease.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you